Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, et al
it can help increase stomach acid production, which supports the breakdown of food and improves nutrient absorption
Some UHC Medicare Advantage plans have begun offering limited coverage, particularly under additional FDA-approved indications such as Wegovys cardiovascular indication (PEAK does not accept Medicare Advantage plans)
Finally, GLP-1 increases production of brown fat (also known as brown adipose tissue ) in the body, say researchers reporting in the journal Diabetes
However, this remains an evolving area of research
Market Projections and Access Considerations Analyst projections suggest the GLP-1 market could reach $150 billion by 2030, driven by expanding indications and growing patient populations ^42